Cargando…
Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds
Discover potential biomarkers of the response for anti-cancer therapies, including traditional Chinese medicine (TCM), is a critical but much different task in the field of cancer research. Based on accumulated data and sophisticated methods, multi-omics analysis provides a feasible strategy for the...
Autores principales: | Li, Ruxue, Zhou, Wuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450078/ https://www.ncbi.nlm.nih.gov/pubmed/36091949 http://dx.doi.org/10.1016/j.heliyon.2022.e09616 |
Ejemplares similares
-
Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616]
por: Li, Ruxue, et al.
Publicado: (2022) -
Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
por: Wang, Yanghao, et al.
Publicado: (2023) -
Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer
por: Li, Ju-Yueh, et al.
Publicado: (2020) -
Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy
por: Chen, Fanghua, et al.
Publicado: (2022) -
Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
por: Li, Shiqi, et al.
Publicado: (2022)